Hesham School of Medical Sciences-Kumamoto Nasser

Dr. Hesham School of Medical Sciences-Kumamoto Nasser

orcid

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2022 in Nature
Verified
Journal Article
Open access
PDF file
RSRigel Suzuki
Rigel Suzuki
DYDaichi Yamasoba
Daichi Yamasoba
IKIzumi Kimura
Izumi Kimura
LWLei Wang
Lei Wang
MKMai Kishimoto
Mai Kishimoto
KSKei Sato
Kei Sato
The emergence of the Omicron variant of SARS-CoV-2 is an urgent global health concern 1 . In this study, our statistical modelling suggests that Omicron has spread more rapidly than the Delta variant in several countries including South Africa. Cell culture experiments showed Omicron to be less fusogenic than Delta and than an ancestral strain of SARS-CoV-2. Although the spike (S) protein of Delta is efficiently cleaved into two subunits, which facilitates cell–cell fusion 2,3 , the Omicron S protein was less efficiently cleaved compared to the S proteins of Delta and ancestral SARS-CoV-2. Furthermore, in a hamster model, Omicron showed decreased lung infectivity and was less pathogenic compared to Delta and ancestral SARS-CoV-2. Our multiscale investigations reveal the virological characteristics of Omicron, including rapid growth in the human population, lower fusogenicity and attenuated pathogenicity.

25 November 2021 in Nature
Verified
Journal Article
Open access
PDF file
SASaito Akatsuki
Saito Akatsuki
TITakashi Irie
Takashi Irie
RSRigel Suzuki
Rigel Suzuki
TMTadashi Maemura
Tadashi Maemura
HNHesham School of Medical Sciences-Kumamoto Nasser
Hesham School of Medical Sciences-Kumamoto Nasser
YYYue Yuan
Yue Yuan
During the current coronavirus disease 2019 (COVID-19) pandemic, a variety of mutations have accumulated in the viral genome of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and, at the time of writing, four variants of concern are considered to be potentially hazardous to human society1. The recently emerged B.1.617.2/Delta variant of concern is closely associated with the COVID-19 surge that occurred in India in the spring of 2021 (ref. 2). However, the virological properties of B.1.617.2/Delta remain unclear. Here we show that the B.1.617.2/Delta variant is highly fusogenic and notably more pathogenic than prototypic SARS-CoV-2 in infected hamsters. The P681R mutation in the spike protein, which is highly conserved in this lineage, facilitates cleavage of the spike protein and enhances viral fusogenicity. Moreover, we demonstrate that the P681R-bearing virus exhibits higher pathogenicity compared with its parental virus. Our data suggest that the P681R mutation is a hallmark of the virological phenotype of the B.1.617.2/Delta variant and is associated with enhanced pathogenicity.

16 May 2023 in Nature Communications
Verified
Journal Article
Open access
PDF file
TTTomokazu Tamura
Tomokazu Tamura
JIJumpei Ito
Jumpei Ito
KUKeiya Uriu
Keiya Uriu
JZJiri Zahradnik
Jiri Zahradnik
IKIzumi Kida
Izumi Kida
TUTakamasa Ueno
Takamasa Ueno
In late 2022, SARS-CoV-2 Omicron subvariants have become highly diversified, and XBB is spreading rapidly around the world. Our phylogenetic analyses suggested that XBB emerged through the recombination of two cocirculating BA.2 lineages, BJ.1 and BM.1.1.1 (a progeny of BA.2.75), during the summer of 2022. XBB.1 is the variant most profoundly resistant to BA.2/5 breakthrough infection sera to date and is more fusogenic than BA.2.75. The recombination breakpoint is located in the receptor-binding domain of spike, and each region of the recombinant spike confers immune evasion and increases fusogenicity. We further provide the structural basis for the interaction between XBB.1 spike and human ACE2. Finally, the intrinsic pathogenicity of XBB.1 in male hamsters is comparable to or even lower than that of BA.2.75. Our multiscale investigation provides evidence suggesting that XBB is the first observed SARS-CoV-2 variant to increase its fitness through recombination rather than substitutions.

11 May 2023 in Nature Communications
Verified
Journal Article
Open access
PDF file
JIJumpei Ito
Jumpei Ito
RSRigel Suzuki
Rigel Suzuki
KUKeiya Uriu
Keiya Uriu
YIYukari Itakura
Yukari Itakura
JZJiri Zahradnik
Jiri Zahradnik
KSKei Sato
Kei Sato
In late 2022, various Omicron subvariants emerged and cocirculated worldwide. These variants convergently acquired amino acid substitutions at critical residues in the spike protein, including residues R346, K444, L452, N460, and F486. Here, we characterize the convergent evolution of Omicron subvariants and the properties of one recent lineage of concern, BQ.1.1. Our phylogenetic analysis suggests that these five substitutions are recurrently acquired, particularly in younger Omicron lineages. Epidemic dynamics modelling suggests that the five substitutions increase viral fitness, and a large proportion of the fitness variation within Omicron lineages can be explained by these substitutions. Compared to BA.5, BQ.1.1 evades breakthrough BA.2 and BA.5 infection sera more efficiently, as demonstrated by neutralization assays. The pathogenicity of BQ.1.1 in hamsters is lower than that of BA.5. Our multiscale investigations illuminate the evolutionary rules governing the convergent evolution for known Omicron lineages as of 2022.

15 February 2016 in The Journal of Immunology
Verified
Journal Article
Closed access
PDF file
MHMichihiro Hashimoto
Michihiro Hashimoto
FBFarzana Bhuyan
Farzana Bhuyan
MHMasateru Hiyoshi
Masateru Hiyoshi
ONOsamu Noyori
Osamu Noyori
HNHesham School of Medical Sciences-Kumamoto Nasser
Hesham School of Medical Sciences-Kumamoto Nasser
SSShinya Suzu
Shinya Suzu
Tunneling nanotubes (TNTs), the long membrane extensions connecting distant cells, have emerged as a novel form of cell-to-cell communication. However, it is not fully understood how and to what extent TNTs contribute to intercellular spread of pathogens including HIV-1. In this study, we show that HIV-1 promotes TNT formation per se via its protein Nef and a cellular protein M-Sec, which appears to mediate approximately half of viral spread among monocyte-derived macrophages (MDMs). A small compound that inhibits M-Sec–induced TNT formation reduced HIV-1 production by almost half in MDMs. Such inhibition was not observed with Nef-deficient mutant HIV-1 that fails to promote TNT formation and replicates less efficiently than the wild-type HIV-1 in MDMs. The TNT inhibitor–sensitive/Nef-promoting viral production was also observed in a T cell line ectopically expressing M-Sec, but not in another M-Sec− T cell line. Our results suggest the importance of TNTs in HIV-1 spread among MDMs and might answer the long-standing question how Nef promotes HIV-1 production in a cell type–specific manner.

8 February 2024 in Nature Communications
Verified
Journal Article
Open access
PDF file
TTTomokazu Tamura
Tomokazu Tamura
TITakashi Irie
Takashi Irie
SDSayaka Deguchi
Sayaka Deguchi
HYHisano Yajima
Hisano Yajima
MTMasumi Tsuda
Masumi Tsuda
TFTakasuke Fukuhara
Takasuke Fukuhara
Circulation of SARS-CoV-2 Omicron XBB has resulted in the emergence of XBB.1.5, a new Variant of Interest. Our phylogenetic analysis suggests that XBB.1.5 evolved from XBB.1 by acquiring the S486P spike (S) mutation, subsequent to the acquisition of a nonsense mutation in ORF8. Neutralization assays showed similar abilities of immune escape between XBB.1.5 and XBB.1. We determine the structural basis for the interaction between human ACE2 and the S protein of XBB.1.5, showing similar overall structures between the S proteins of XBB.1 and XBB.1.5. We provide the intrinsic pathogenicity of XBB.1 and XBB.1.5 in hamsters. Importantly, we find that the ORF8 nonsense mutation of XBB.1.5 resulted in impairment of MHC suppression. In vivo experiments using recombinant viruses reveal that the XBB.1.5 mutations are involved with reduced virulence of XBB.1.5. Together, our study identifies the two viral functions defined the difference between XBB.1 and XBB.1.5.